⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma

Official Title: A Phase 3 Randomized Study Comparing Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible

Study ID: NCT05257083

Study Description

Brief Summary: The purpose of this study is to compare the efficacy of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple myeloma patients.

Detailed Description: Multiple myeloma (MM) is a malignant plasma cell disorder characterized by the production of monoclonal immunoglobulin (Ig) proteins or protein fragments (M proteins) that have lost their function. JNJ-68284528 (ciltacabtagene autoleucel \[cilta-cel\]) is an autologous chimeric antigen receptor T cell (CAR-T) therapy that targets B-cell maturation antigen (BCMA) that is being evaluated to treat participants with multiple myeloma. The primary hypothesis is that in transplant-eligible participants with newly diagnosed multiple myeloma (NDMM), cilta-cel will significantly improve progression-free survival (PFS) and Sustained MRD-negative CR rate compared with Autologous Stem Cell Transplant (ASCT). Approximately 750 participants (375 per arm) will be randomly assigned in a 1:1 ratio into 2 arms.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

University of Arkansas, Little Rock, Arkansas, United States

City of Hope, Duarte, California, United States

UC San Diego Health Moores Cancer Center, San Diego, California, United States

University of California San Francisco (UCSF), San Francisco, California, United States

Stanford University, Stanford, California, United States

Moffitt Cancer Center, Tampa, Florida, United States

University of Chicago, Chicago, Illinois, United States

University of Iowa, Iowa City, Iowa, United States

The University of Kansas Cancer Center, Kansas City, Kansas, United States

University of Maryland Medical Center, Baltimore, Maryland, United States

Boston Medical Center, Boston, Massachusetts, United States

Mayo Clinic Hospital - Rochester, Rochester, Minnesota, United States

Mount Sinai Medical Venter, New York, New York, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

University of Rochester, Rochester, New York, United States

Levine Cancer Institute, Charlotte, North Carolina, United States

The Ohio State University, Columbus, Ohio, United States

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Univ. of Pittsburgh Medical Center (UPMC), Pittsburgh, Pennsylvania, United States

University of Texas Southwestern Medical Center, Dallas, Texas, United States

University of Virginia, Charlottesville, Virginia, United States

University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States

Medical College Wisconsin, Milwaukee, Wisconsin, United States

Royal Adelaide Hospital, Adelaide, , Australia

Princess Alexandra Hospital, Brisbane, , Australia

Royal Prince Alfred Hospital, Camperdown, , Australia

Royal Brisbane and Womens Hospital, Herston, , Australia

Alfred Health, Melbourne, , Australia

Austin Hospital, Melbourne, , Australia

Peter MacCallum Cancer Centre, Melbourne, , Australia

St. Vincent's Hospital, Melbourne, , Australia

Fiona Stanley Hospital, Murdoch, , Australia

Calvary Mater Newcastle Hospital, Waratah, , Australia

Westmead Hospital, Westmead, , Australia

UZA, Antwerpen, , Belgium

UZ Gent, Gent, , Belgium

UZ Leuven, Leuven, , Belgium

Tom Baker Cancer Center, Calgary, , Canada

Cross Cancer Institute, Edmonton, , Canada

McMaster University, Hamilton, , Canada

Hopital Maisonneuve-Rosemont, Montréal, , Canada

Mcgill University Health Centre, Montréal, , Canada

Ottawa Hospital Research Institute, Ottawa, , Canada

(CHU) Centre Hospitalier Universitaire de Quebec Laval, Québec, , Canada

Princess Margaret Cancer Centre, Toronto, , Canada

Vancouver General Hospital, Vancouver, , Canada

Fakultni nemocnice Brno, Brno, , Czechia

Fakultni nemocnice Hradec Kralove, Králová, , Czechia

Fakutni nemocnice Ostrava, Ostrava, , Czechia

Fakultni nemocnice Plzen, Plzen, , Czechia

Vseobecna fakultni nemocnice v Prague, Prague, , Czechia

CHRU de Lille - Hopital Claude Huriez, Lille, , France

Hospices Civils De Lyon, Lyon, , France

CHU De Nantes - Hématologie Clinique, Nantes, , France

Aphp Direction, Paris, , France

CHU Poitiers - Pôle régional de Cancérologie, Poitiers, , France

Hopital Saint Louis - Aphp Hôpitaux Universitaires Saint-Louis, Saint-Louis, , France

CHU de Toulouse, Toulouse, , France

University Hospital of Cologne, Cologne, , Germany

Dresden, Dresden, , Germany

Universitätsklinikum Hamburg - Eppendorf, Hamburg, , Germany

Nationales Centrum für Tumorerkrankungen (NCT) Abt. Medizinische Onkologie, Heidelberg, , Germany

University Hospital of Leipzig, Leipzig, , Germany

Tübingen, Tübingen, , Germany

University Hospital of Würzburg, Würzburg, , Germany

Attikon University General Hospital of Attica, Athens, , Greece

'G. Papanikolaou' Hospital of Thessaloniki, Thessaloníki, , Greece

Hadassah University Hospita - Ein Kerem, Jerusalem, , Israel

Sheba Medical Center, Ramat Gan, , Israel

Tel Aviv Sourasky Medical Center, Tel Aviv, , Israel

Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi Di Ancona, Ancona, , Italy

Policlinico S Orsola Malpighi, Bologna, , Italy

A.O.U. Policlinico S. Martino - Ematologia, Genova, , Italy

ASST Grande Ospedale Metropolitano Niguarda, Milan, , Italy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milan, , Italy

Fondazione Policlinico Universitario Agostino Gemelli, Roma, , Italy

A.O.U. Citta della Salute e della Scienza di Torino - Presidio Molinette, Turin, Turin, , Italy

Juntendo University Hospital, Bunkyō-Ku, , Japan

Kyushu University Hospital - Hematology/Oncology, Fukuoka, , Japan

Hokkaido University Hospital-Department of Hematology, Hokkaido, , Japan

Hyogo College of Medicine, Hyōgo, , Japan

Kanazawa University Hospital, Kanazawa, , Japan

Nagoya City University Hospital - Department of Hematology & Oncology, Nagoya, , Japan

Okayama University Hospital - Hematology/Oncology, Okayama, , Japan

Osaka metropolitan university hospital, Osaka, , Japan

Japanese Red Cross Medical Center - Hematology, Shibuya, , Japan

Keio University Hospital - Hematology, Shinjuku-Ku, , Japan

Tohoku University Hospital - Hematology, Tōhoku, , Japan

VU Medisch Centrum, Amsterdam, , Netherlands

University Medical Center Groningen, Groningen, , Netherlands

Radboud UMC, Nijmegen, , Netherlands

Erasmus MC, Rotterdam, , Netherlands

UMC Utrecht, Utrecht, , Netherlands

Oslo University Hospital Ullevål - Oncology, Oslo, , Norway

Hospital Universitario Germans Trias i Pujol, Badalona, , Spain

Hospital Clinic de Barcelona, Barcelona, , Spain

Instituto Catalán de Oncología, Barcelona, , Spain

Hospital Universitario Ramón y Cajal, Madrid, , Spain

Hospital General Universitario Gregorio Marañón, Madrid, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

CLINICA UNIV. DE NAVARRA, Pamplona, Pamplona, , Spain

Hospital Universitario de Salamanca, Salamanca, , Spain

Hospital de Santiago de Compostela, Santiago De Compostela, , Spain

Hospital Universitario Virgen del Rocío, Sevilla, , Spain

Hospital Universitario la Fe, Valencia, Valencia, , Spain

Sahlgrenska Universitetssjukhuset, Göteborg, , Sweden

Landstinget i Ostergotland-Universitetssjukhuset i Linkoping, Linköping, , Sweden

Skånes University Hospital Lund, Lund, , Sweden

Akademiska Sjukhuset, Uppsala, , Sweden

Universitaetsspital Basel - Zentrum fur Hamato-Onkologie, Basel, , Switzerland

Bern Inselspital, Bern, , Switzerland

Lausanne CHUV Département d'oncologie, Lausanne, , Switzerland

UniversitaetsSpital Zürich, Zürich, , Switzerland

Queen Elizabeth Medical Centre, Birmingham, , United Kingdom

University Hospital of Wales, Cardiff, , United Kingdom

Leeds Cancer Centre at St. James's University Hospital, Leeds, , United Kingdom

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: